Related Experiment Videos
[Vasomotor activity in the large arterial vessels and arterial hypertension]
1Laboratoires d'hémodynamique de l'hypertension artérielle, hôpital Broussais, Paris.
Insights
Antihypertensive drugs partially address hypertension's hemodynamic issues. Effective treatment also requires improving arterial compliance, reducing heart muscle thickening, and maintaining blood flow.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Hypertension Research
Context:
- Hypertension traditionally viewed as an arteriolar disease.
- Great arteries are also implicated in hypertensive disease.
- Current antihypertensive agents may not fully correct hemodynamic issues.
Purpose:
- To test the hypothesis that antihypertensive agents only partially correct hemodynamic abnormalities in hypertension.
- To identify additional therapeutic objectives for vasodilator antihypertensive therapy.
Summary:
- Study hypothesizes that current antihypertensive drugs offer incomplete hemodynamic correction.
- Suggests therapeutic goals should include arterial structural changes, left ventricular hypertrophy regression, blood pressure variability reduction, and regional blood flow maintenance.
- Highlights the importance of addressing great artery involvement in hypertension.
Impact:
- Broadens the therapeutic targets for hypertension management.
- Emphasizes a more comprehensive approach to treating hypertensive cardiovascular and vascular disease.
- Informs future research on vasodilator antihypertensive therapy and arterial remodeling.
Abstract:
Hypertension has long been considered to be a disease of the arterioles but it also concerns the great arteries. The hypothesis for this study was that the antihypertensive agents used in the large multicenter trials only partially correct the hemodynamic abnormalities of hypertension. The regression of the structural arterial changes responsible for the decreased arterial compliance, the regression of left ventricular hypertrophy without alteration of systolic function, the decrease in the variability of the blood pressure and the maintenance of regional blood flow should also be considered as therapeutic objectives for vasodilator antihypertensive therapy.